RedHill Biopharma Ltd. (RDHL)
$0.61-3.17%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2M
- Avg volume
- 163.7K
- Beta
- 4.90
- P/E (TTM)
- -0.31
- Short % float
- 1.31%
- Days to cover
- 1.0
- SI change
- +49.7%
- 1W
- +5.17%
- 1M
- -3.17%
- 3M
- -37.76%
- YTD
- -40.78%
- vs SPY 1W
- +6.36%
- vs SPY 1M
- -6.50%
- vs SPY 3M
- -40.15%
- vs SPY YTD
- -52.53%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- KZIABUYKazia Therapeutics LimitedRECOVERYQ 5$13.20-1.57%
- CELZBUYCreative Medical Technology Holdings, Inc.RECOVERYQ -9$1.21-7.63%
- CEROBUYCERo Therapeutics Holdings, Inc.CRISISQ -31$0.01+0.00%
- FOCLSELLCRISISQ 13$4.18+1.21%
- OVIDBUYOvid Therapeutics Inc.RECOVERYQ -8$2.82+0.71%
- RCUSBUYArcus Biosciences, Inc.RECOVERYQ 19$30.12-0.73%
- RMTIBUYRockwell Medical, Inc.RECOVERYQ 6$7.90-2.47%
- INNVSELLInnovAge Holding Corp.BEARQ 14$11.02+0.55%
- GOSSSELLGossamer Bio, Inc.CRISISQ -26$0.17+13.33%
- KYMRBUYKymera Therapeutics, Inc.BULLQ 27$121.05+1.04%
- ROIVBUYRoivant Sciences Ltd.BULLQ 31$36.36+0.17%
- STXSBUYStereotaxis, Inc.RECOVERYQ 5$1.42+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 13
- GROWTH
- 38
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-16.3%
GROSS61
OP-107
NET-101
[VALUATION]
P/E TTM-0.31
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.56
P/B0.26
P/FCF-
EV/EBITDA0.23
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E25.07
ALTMAN Z-
CURR RATIO0.34
ND/EBITDA-
BETA4.90
